Known T2D drug targets NCOA1 and PPARA, T2D disease genes HNF4A, and the PCOS disease genes AR, CYP11A1 were also enriched in same functional categories and pathways of PPARG. This evidence concerns the gene PPARG and polycystic ovary syndrome.